相似文献
1
Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects.
Diabetes Care. 2010 Sep;33(9):2071-3. doi: 10.2337/dc10-0484. Epub 2010 Jun 2.
2
Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control.
J Lab Clin Med. 2000 Dec;136(6):441-8. doi: 10.1067/mlc.2000.111004.
3
Maternal Lipids May Predict Fetal Growth in Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus Pregnancies.
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016 Nov 1;37(2-3):99-105. doi: 10.1515/prilozi-2016-0022.
4
Triglyceride and cholesterol levels during pregnancy in type I, type II and gestational diabetic women.
Boll Soc Ital Biol Sper. 1984 Nov 30;60(11):2055-9.
5
[Cholesterol, HDL-cholesterol, triglycerides and beta-lipoprotein in diabetic pregnancy].
Zentralbl Gynakol. 1995;117(1):17-22.
6
Increases in serum lipids during pregnancy in type 1 diabetic women with nephropathy.
Diabet Med. 1994 Apr;11(3):262-7. doi: 10.1111/j.1464-5491.1994.tb00269.x.
7
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
Diabet Med. 2005 Jan;22(1):21-5. doi: 10.1111/j.1464-5491.2004.01336.x.
8
Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes.
Clin Sci (Lond). 2004 Jan;106(1):93-8. doi: 10.1042/CS20030175.
9
Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition.
J Clin Pathol. 2000 Dec;53(12):917-23. doi: 10.1136/jcp.53.12.917.
10
Maternal serum triglyceride at 24--32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens.
Obstet Gynecol. 2001 May;97(5 Pt 1):776-80. doi: 10.1016/s0029-7844(01)01328-x.
引用本文的文献
1
Associations between maternal glycemic level and lipid profile and adverse pregnancy outcomes in women with type 2 diabetes mellitus: a retrospective study from China.
PeerJ. 2025 Jun 4;13:e19502. doi: 10.7717/peerj.19502. eCollection 2025.
2
Association between maternal blood lipids and neonatal hypoglycaemia in pregnancy with gestational diabetes mellitus: a cohort study.
Lipids Health Dis. 2024 Jun 7;23(1):170. doi: 10.1186/s12944-024-02168-z.
3
Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus.
Int J Mol Sci. 2024 Mar 21;25(6):3559. doi: 10.3390/ijms25063559.
4
Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study.
Acta Obstet Gynecol Scand. 2024 Feb;103(2):257-265. doi: 10.1111/aogs.14688. Epub 2023 Dec 22.
5
Management of type 2 diabetes in pregnancy: a narrative review.
Front Endocrinol (Lausanne). 2023 Jul 21;14:1193271. doi: 10.3389/fendo.2023.1193271. eCollection 2023.
6
A facility-based study of lipids, glucose levels and their correlates among pregnant women in public hospitals of northern Ethiopia.
PLoS One. 2023 Jun 6;18(6):e0279595. doi: 10.1371/journal.pone.0279595. eCollection 2023.
7
Impact Of Prepregnancy Overweight And Obesity On Treatment Modality And Pregnancy Outcome In Women With Gestational Diabetes Mellitus.
Front Endocrinol (Lausanne). 2022 May 19;13:799625. doi: 10.3389/fendo.2022.799625. eCollection 2022.
8
Capillary Triglycerides in Late Pregnancy-Challenging to Measure, Hard to Interpret: A Cohort Study of Practicality.
Nutrients. 2021 Apr 13;13(4):1266. doi: 10.3390/nu13041266.
9
Metabolic profile during pregnancy in BRISA birth cohorts of Ribeirão Preto and São Luís, Brazil.
Braz J Med Biol Res. 2020 Dec 7;54(1):e10253. doi: 10.1590/1414-431X202010253. eCollection 2020.
10
Association between maternal blood lipids levels during pregnancy and risk of small-for-gestational-age infants.
Sci Rep. 2020 Nov 16;10(1):19865. doi: 10.1038/s41598-020-76845-1.
本文引用的文献
1
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
Diabet Med. 2008 Dec;25(12):1406-11. doi: 10.1111/j.1464-5491.2008.02613.x.
2
Fetal programming of glucose-insulin metabolism.
Mol Cell Endocrinol. 2009 Jan 15;297(1-2):4-9. doi: 10.1016/j.mce.2008.06.020. Epub 2008 Jul 10.
3
Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus.
Diabetes Care. 2008 Sep;31(9):1858-63. doi: 10.2337/dc08-0039. Epub 2008 Jul 7.
4
Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes.
Diabetes Metab Res Rev. 2008 Sep;24(6):465-71. doi: 10.1002/dmrr.867.
5
Maternal C-reactive protein and developmental programming of atherosclerosis.
Am J Obstet Gynecol. 2008 Mar;198(3):281.e1-5. doi: 10.1016/j.ajog.2007.11.027.
6
The metabolic syndrome--a new worldwide definition.
Lancet. 2005;366(9491):1059-62. doi: 10.1016/S0140-6736(05)67402-8.
7
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study.
Diabetes Care. 2003 Jan;26(1):16-23. doi: 10.2337/diacare.26.1.16.
8
The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis.
FASEB J. 2002 Sep;16(11):1348-60. doi: 10.1096/fj.02-0226rev.
9
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.
Circ Res. 2001 Nov 23;89(11):991-6. doi: 10.1161/hh2301.099646.
10
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.
Lancet. 1999 Oct 9;354(9186):1234-41. doi: 10.1016/S0140-6736(99)02131-5.
Zotero 插件